HuagongsheHuagongshe Chemistry Print Report · For research reference only
(R)-2-(5-methylisoxazol-3-yl)but-3-yn-2-ol → HCID 86693343, compound
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | (R)-2-(5-methylisoxazol-3-yl)but-3-yn-2-ol | HCID 58221468 | — |
| Reactant | HCID 86693344 | HCID 86693344 | — |
| Product | HCID 86693343 | HCID 86693343 | 20% |
Reaction Steps
10-bromo-3-(trifluoromethyl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine-2-carboxamide was reacted with (2R)-2-(5-methylisoxazol-3-yl)but-3-yn-2-ol via General Procedure E to afford 19 mg (20%) of 10-[(3R)-3-hydroxy-3-(5-methylisoxazol-3-yl)but-1-ynyl]-3-(trifluoromethyl)-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepine-2-carboxamide.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US09034866B2 |
| Source dataset | uspto-grants-2015_05 |
| ORD ID | ord-af4d7739b48e4b4fa3fb54cac8455b5e |
| Source note | uspto-grants-2015_05 |